[go: up one dir, main page]

HK1033277A1 - Emulsion preconcentrates containing cyclosporin or a macrolide - Google Patents

Emulsion preconcentrates containing cyclosporin or a macrolide Download PDF

Info

Publication number
HK1033277A1
HK1033277A1 HK01104070A HK01104070A HK1033277A1 HK 1033277 A1 HK1033277 A1 HK 1033277A1 HK 01104070 A HK01104070 A HK 01104070A HK 01104070 A HK01104070 A HK 01104070A HK 1033277 A1 HK1033277 A1 HK 1033277A1
Authority
HK
Hong Kong
Prior art keywords
macrolide
containing cyclosporin
emulsion preconcentrates
emulsion
preconcentrates containing
Prior art date
Application number
HK01104070A
Other languages
English (en)
Chinese (zh)
Other versions
HK1033277B (en
Inventor
Ambuhl Michael
Luckel Barbara
Richter Friedrich
Haberlin Barbara
Meinzer Armin
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27269231&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1033277(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9804742.6A external-priority patent/GB9804742D0/en
Priority claimed from GBGB9805104.8A external-priority patent/GB9805104D0/en
Priority claimed from GBGB9805199.8A external-priority patent/GB9805199D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Priority to HK03106974.4A priority Critical patent/HK1056310B/xx
Priority to HK03106973.5A priority patent/HK1056309B/xx
Publication of HK1033277A1 publication Critical patent/HK1033277A1/xx
Publication of HK1033277B publication Critical patent/HK1033277B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK01104070.4A 1998-03-06 1999-03-04 Emulsion preconcentrates containing cyclosporin or a macrolide HK1033277B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HK03106974.4A HK1056310B (en) 1998-03-06 2001-06-13 Emulsion preconcentrates containing cyclosporin or a macrolide
HK03106973.5A HK1056309B (en) 1998-03-06 2001-06-13 Emulsion preconcentrates containing cyclosporin or a macrolide

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB9804742.6A GB9804742D0 (en) 1998-03-06 1998-03-06 Organic compounds
GB9804742 1998-03-06
GBGB9805104.8A GB9805104D0 (en) 1998-03-10 1998-03-10 Organic compounds
GB9805104 1998-03-10
GBGB9805199.8A GB9805199D0 (en) 1998-03-11 1998-03-11 Organic compounds
GB9805199 1998-03-11
PCT/EP1999/001415 WO1999044584A1 (en) 1998-03-06 1999-03-04 Emulsion preconcentrates containing cyclosporin or a macrolide

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
HK03106974.4A Division HK1056310B (en) 1998-03-06 2001-06-13 Emulsion preconcentrates containing cyclosporin or a macrolide
HK03106973.5A Division HK1056309B (en) 1998-03-06 2001-06-13 Emulsion preconcentrates containing cyclosporin or a macrolide

Related Child Applications (2)

Application Number Title Priority Date Filing Date
HK03106974.4A Addition HK1056310B (en) 1998-03-06 2001-06-13 Emulsion preconcentrates containing cyclosporin or a macrolide
HK03106973.5A Addition HK1056309B (en) 1998-03-06 2001-06-13 Emulsion preconcentrates containing cyclosporin or a macrolide

Publications (2)

Publication Number Publication Date
HK1033277A1 true HK1033277A1 (en) 2001-08-24
HK1033277B HK1033277B (en) 2003-10-31

Family

ID=

Also Published As

Publication number Publication date
IT1313550B1 (it) 2002-09-09
IL138248A0 (en) 2001-10-31
KR20010041657A (ko) 2001-05-25
PE20000324A1 (es) 2000-04-13
JP2004189753A (ja) 2004-07-08
WO1999044584A1 (en) 1999-09-10
FR2853546B1 (fr) 2006-04-07
TWI236912B (en) 2005-08-01
CZ20003222A3 (cs) 2000-12-13
TW200422057A (en) 2004-11-01
ID25908A (id) 2000-11-09
EP1354582A2 (en) 2003-10-22
TR200002586T2 (tr) 2000-11-21
AU2836199A (en) 1999-09-20
ITMI990452A1 (it) 2000-09-05
FR2775596A1 (fr) 1999-09-10
DE69920668T2 (de) 2005-10-06
CA2322845A1 (en) 1999-09-10
EP1059913A1 (en) 2000-12-20
FR2775596B1 (fr) 2004-12-24
NO331800B1 (no) 2012-04-02
DE19983012T1 (de) 2001-02-01
FR2800277B1 (fr) 2004-06-25
SK285139B6 (sk) 2006-07-07
IL138248A (en) 2006-06-11
GB2350791A (en) 2000-12-13
AU749217B2 (en) 2002-06-20
JP2002505271A (ja) 2002-02-19
BR9908597A (pt) 2000-11-14
HUP0101080A2 (hu) 2001-08-28
HUP0101080A3 (en) 2001-12-28
ATE277599T1 (de) 2004-10-15
NZ506644A (en) 2004-02-27
TWI248368B (en) 2006-02-01
CN1195495C (zh) 2005-04-06
HK1034038A1 (en) 2001-10-12
NO20004299D0 (no) 2000-08-29
GB2350791B (en) 2003-04-02
FR2881956A1 (fr) 2006-08-18
CA2322845C (en) 2009-12-08
KR100443306B1 (ko) 2004-08-09
CO4930289A1 (es) 2000-06-27
BE1013423A5 (fr) 2002-01-15
CN1292684A (zh) 2001-04-25
TWI257870B (en) 2006-07-11
FR2800277A1 (fr) 2001-05-04
BE1012400A5 (fr) 2000-10-03
NO20004299L (no) 2000-08-29
GB0021495D0 (en) 2000-10-18
EP1354582A3 (en) 2004-06-09
CZ301967B6 (cs) 2010-08-18
BE1013648A5 (fr) 2002-05-07
AR015729A1 (es) 2001-05-16
FR2853546A1 (fr) 2004-10-15
SK13192000A3 (sk) 2001-02-12
MY129274A (en) 2007-03-30
EP1059913B1 (en) 2004-09-29
ES2228014T3 (es) 2005-04-01
PT1059913E (pt) 2005-01-31
DE69920668D1 (de) 2004-11-04

Similar Documents

Publication Publication Date Title
EP1354582A3 (en) Emulsion preconcentrates containing cyclosporin or a macrolide
MY129435A (en) Pharmaceutical microemulsion preconcentrates
WO2002082783A3 (en) Rotational mechanism for a wireless communication device
EP1229651A3 (en) Enhanced field programmable gate array
KR960702321A (ko) 용해제 및 이 용해제를 함유하는 외용제제 (solvent and external preparations containing the same)
EP1473474A3 (en) A hub unit for an automobile
GB2367004B (en) A cyclosporin containing composition in the form of a capsule
AU5541800A (en) Oil-in-water emulsion comprising gellan and a particular surfactant and uses
EP0607897A3 (en) Hydraulically-damped, active engine support.
AU2859499A (en) (streptomyces) sp. producing tautomycetin and immunosuppressant comprising tautomycetin as active ingredient
WO2000009085A3 (en) Oral formulation containing cyclosporin
EP0987616A3 (en) Control device
WO2001076553A3 (en) Method and device for enhanced transdermal drug delivery
WO2001095096A3 (en) Data path engine (dpe)
EP0991296A3 (en) Variable disposition wide band multiway loudspeakers
GB0229289D0 (en) Emulsion preconcentrates containing cyclosporin or a macrolide
USD425385S (en) Fitting
WO2002069911A3 (de) WIRKSTOFFKOMBINATIONEN AUS α-LIPONSÄURE UND BIOCHINONEN
HK1056309B (en) Emulsion preconcentrates containing cyclosporin or a macrolide
HK1033277B (en) Emulsion preconcentrates containing cyclosporin or a macrolide
Reinhart What no likud government did
EP0780867A3 (en) Vacuum switching device
BROOKS A GIFT OF DREAMS
SI1059913T1 (en) Emulsion preconcentrates containing cyclosporin or a macrolide
IL193595A0 (en) A polypeptide containing an immunogenic portion of a m. tuberculosis antigen, and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130304